about
sameAs
HIV treatment cascade in tuberculosis patientsUptake of workplace HIV counselling and testing: a cluster-randomised trial in Zimbabwe.Epidemiology of tuberculosis in a high HIV prevalence population provided with enhanced diagnosis of symptomatic disease.Comparison of indoor contact time data in Zambia and Western Cape, South Africa suggests targeting of interventions to reduce Mycobacterium tuberculosis transmission should be informed by local data.The effects of HIV on the sensitivity of a whole blood IFN-gamma release assay in Zambian adults with active tuberculosis.Annual risk of tuberculous infection using different methods in communities with a high prevalence of TB and HIV in Zambia and South AfricaDevelopment of a bacteriophage phage replication assay for diagnosis of pulmonary tuberculosis.Risk factors associated with positive QuantiFERON-TB Gold In-Tube and tuberculin skin tests results in Zambia and South Africa.The association between household socioeconomic position and prevalent tuberculosis in Zambia: a case-control study.The Millennium Development Goals: a cross-sectoral analysis and principles for goal setting after 2015 Lancet and London International Development Centre Commission.Evaluation of tuberculosis diagnostics: establishing an evidence base around the public health impact.High prevalence of tuberculosis and insufficient case detection in two communities in the Western Cape, South Africa.Risk factors for infection and disease in child contacts of multidrug-resistant tuberculosis: a cross-sectional study.Prevalence and risk factors for infection of bovine tuberculosis in indigenous cattle in the Serengeti ecosystem, Tanzania.Effect of home-based interventions on virologic outcomes in adults receiving antiretroviral therapy in Africa: a meta-analysisCan we control tuberculosis in high HIV prevalence settings?Implementation Research to Inform the Use of Xpert MTB/RIF in Primary Health Care Facilities in High TB and HIV Settings in Resource Constrained SettingsThe promises and challenges of pre-exposure prophylaxis as part of the emerging paradigm of combination HIV preventionIsoniazid preventive therapy and risk for resistant tuberculosis.Effects of genetic variability of Mycobacterium tuberculosis strains on the presentation of disease.The association of hyperglycaemia with prevalent tuberculosis: a population-based cross-sectional study.Age- and Sex-Specific Social Contact Patterns and Incidence of Mycobacterium tuberculosis Infection.Integrating tuberculosis and HIV services for people living with HIV: costs of the Zambian ProTEST Initiative.The research agenda for improving health policy, systems performance, and service delivery for tuberculosis control: a WHO perspective.How human immunodeficiency virus voluntary testing can contribute to tuberculosis control.Impact of a novel molecular TB diagnostic system in patients at high risk of TB mortality in rural South Africa (Uchwepheshe): study protocol for a cluster randomised trial.ZAMSTAR, The Zambia South Africa TB and HIV Reduction Study: design of a 2 x 2 factorial community randomized trialCosts of measures to control tuberculosis/HIV in public primary care facilities in Cape Town, South Africa.Tuberculosis infection in Zambia: the association with relative wealth.Diabetes mellitus in Zambia and the Western Cape province of South Africa: Prevalence, risk factors, diagnosis and management.Screening and preventive therapy for tuberculosis.Management of children exposed to multidrug-resistant Mycobacterium tuberculosis.Hearing loss in patients on treatment for drug-resistant tuberculosis.Bovine tuberculosis at the human-livestock-wildlife interface: is it a public health problem in Tanzania? A review.'One Health' infectious diseases surveillance in Tanzania: are we all on board the same flight?Tuberculosis cross-species transmission in Tanzania: towards a One-Health concept.High treatment success in children treated for multidrug-resistant tuberculosis: an observational cohort study.How soon after infection with HIV does the risk of tuberculosis start to increase? A retrospective cohort study in South African gold miners.Effect of household and community interventions on the burden of tuberculosis in southern Africa: the ZAMSTAR community-randomised trial.A trial of mass isoniazid preventive therapy for tuberculosis control.
P50
Q26782208-3BC6C278-09A7-41DA-AC65-9694E56A6E6BQ30483139-6A35B18D-B9FB-47E2-8C5F-AA0B592B77E6Q30828660-DAA87FCE-5564-42B5-BC28-1093AD29D0EDQ31043943-6DB7E82B-2B12-49CC-8193-5175D611CB2CQ33344474-731E6910-41EB-4BCD-A859-AF163B6249A7Q33516016-0F65D0AA-178A-4D00-BA12-482BB23526DEQ33712762-A1E6ED98-5568-4F97-80CB-61ECD3A43559Q33869437-6FE8C3B2-9A71-4419-8CEA-9298693258ACQ33940770-DEEAF325-E874-415A-AD5F-E099FFB6704EQ34137408-E748BFCC-07B7-4B78-8F13-63E20FC3A912Q34224000-08C1BFF2-1E35-4711-83C0-292C27683E8FQ34656147-F96CA934-415B-4407-9697-C5287BB2689AQ34974337-8D877890-77B4-40A7-914E-C43F306DF859Q35078772-A9DB0577-D3E1-4B8A-91A2-8DD9D6614A74Q35114171-460DE87B-4E02-4DCC-A802-BB96C2B8A6F0Q35132006-57FDC244-8B1F-4A68-9AC9-397DF730D6B0Q35647887-739BC58E-E73A-49A0-8989-AF83AE36ABC8Q35875723-9F9D605B-AEAD-467C-B69D-6EF3B9341FB4Q36029457-8FDD81B0-E05C-4E1B-8BB2-E0AF2DB4F161Q36070678-1A1BB05E-4CCC-4857-A4F9-F80DB062BE13Q36213598-4EB88F7E-54E1-44A7-9F87-73F2389BE677Q36446258-588C601F-4518-4017-AF57-AF9406184B37Q36493894-293AFB45-7843-46F3-9F3A-B086B20A6C42Q36937305-55415604-FAE6-427B-B2A7-9C4C8A3EC954Q36937821-EC462D9A-9A8D-46C2-BF6F-C45C5BD4F34CQ36940706-A88E234F-9FA5-48F2-9833-4E1EC5FC2EA6Q36979131-E851D316-E1FA-4503-981B-A4FE32EDD3B6Q37063602-237F7D3F-31B1-44BC-ADB9-7194EBB1DCB4Q37148318-BFF6FAA5-E82A-4C72-A474-0DB8F7C152FDQ37196869-F411A614-1FD6-4055-93CB-A524CACE7AB7Q37635405-476DD9F9-18B6-424F-A9B0-B7FE7514C72CQ37988983-A0B8DC81-A904-4263-B96A-0D19604E3D7BQ38018914-3058A62D-60F9-445F-9DB4-168547853290Q38074702-803E86F5-AEB8-4F89-A878-17767D413BBCQ38074703-AC37F353-1A5F-440B-9F18-3C3393495C0BQ38074704-8FE2BBB8-0005-40CC-860D-48F9556A5662Q38142536-99C29572-8BBD-4778-9645-C0E812E3C5A9Q38475969-EBF54D48-317A-4EF4-A4E8-E280026E8B8DQ38885348-8700B386-2AF7-4DFB-89D5-344A8A3BE1BDQ38947219-546BFD10-19F8-4767-AE4F-2B79BEC77756
P50
description
researcher (ORCID 0000-0002-5929-9524)
@en
wetenschapper
@nl
name
Peter Godfrey-Faussett
@en
Peter Godfrey-Faussett
@nl
type
label
Peter Godfrey-Faussett
@en
Peter Godfrey-Faussett
@nl
prefLabel
Peter Godfrey-Faussett
@en
Peter Godfrey-Faussett
@nl
P31
P496
0000-0002-5929-9524